Successful start-up, commercial-stage biopharmaceutical company identifying, developing, and commercializing novel, patent protected products in selected specialty, rare and ultra-rare disease areas on a global basis.

With the recent acquisition, further diversifies Company’s pipeline, with both commercial products in medical food for the treatment of phenylketonuria (PKU), and promising clinical-stage programs pending for the treatment of epidermolysis bullosa (EB).

The primary responsibility of the CML is to serve as the internal patient liaison for PKU in the innovative metabolic Phe free protein formula for patients with PKU.  The CML will monitor the patient journey and provide feedback to internal Company team members. The CML will learn from the family how their sample trial with product went and support follow through with the primary RD.  The CML will coordinate solutions to logistical issues that are impacting treatment initiation of therapy and initiate access to the appropriate Registered Dietitian Nutritionist (RDN). The CML will coordinate escalation needs as they arise and ensure internal stake holders are made aware of interruptions to the patient process.

The CML will work closely with the contracted DME, coordinating patient education and hand off to the RD for referrals. The CM will interact with RDN’s, physicians, nurses, ancillary staff, patients/families, and advocacy groups to support access to Company products.

The role is a vital part of the growth at Company and will grow to oversee all contract management obligated activities between Company and the DME. The role reports into the Director, Head of Market Access for the U.S.